Literature DB >> 16699612

Expression of the p53 protein and clinical and pathologic correlation in adenocarcinoma of the rectum.

Márcia Teresinha Jurach1, Luise Meurer, Luis Fernando Moreira.   

Abstract

BACKGROUND: p53 is a tumor suppressor gene that has been implicated in the pathogenesis of a wide range of tumors, including colorectal cancer. AIM: To evaluate the prognostic significance of p53 protein expression, and to correlate with clinical and pathologic variables as well as survival. PATIENTS AND METHODS: Immunohistochemical staining for p53 protein was performed in a series of 83 patients with rectal cancer with a follow-up of at least 5 years.
RESULTS: Expression of nuclear protein was positive in 36 (43.4%) of the tumors. We found association between positive p53 and death, local recurrence, distant metastasis and overall recurrence and we also found association between p53 and death, local recurrence, metastasis and overall recurrence when analysis was adjusted to Astler-Coller stage and grade of differentiation.
CONCLUSION: p53 immunoexpression has shown to be an independent prognostic factor in these series.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699612     DOI: 10.1590/s0004-28032006000100006

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  6 in total

1.  Analysis of AC3-33 gene expression in multiple organ cancer and adjacent normal tissue by RNA in situ hybridization.

Authors:  Fen Hu; Shaoqing Yang; Shaobo Lv; Yan Peng; Lijun Meng; Lixia Gou; Xiujun Zhang
Journal:  Oncol Lett       Date:  2015-04-14       Impact factor: 2.967

Review 2.  The prognostic value of the apoptosis pathway in colorectal cancer: a review of the literature on biomarkers identified by immunohistochemistry.

Authors:  Eliane C M Zeestraten; Anne Benard; Marlies S Reimers; Philip C Schouten; Gerrit J Liefers; Cornelis J H van de Velde; Peter J K Kuppen
Journal:  Biomark Cancer       Date:  2013-07-04

3.  Relation between expression of hMLH1 and p53 mRNA genes, in the feces of patients with colorectal carcinoma. Cross-sectional study.

Authors:  Ryanto Karobuana Sitepu; Rosdiana Natzir; Mochammad Hatta; Reno Rudiman; Ibrahim Labeda; Ronald E Lusikooy; Agussalim Bukhari; Upik A Miskad; Burhanuddin Bahar
Journal:  Ann Med Surg (Lond)       Date:  2022-01-06

4.  Prognostic Value of Immunohistochemical Markers for Locally Advanced Rectal Cancer.

Authors:  Anas Taha; Stephanie Taha-Mehlitz; Stephanie Petzold; Sergey L Achinovich; Dmitry Zinovkin; Bassey Enodien; Md Zahidul I Pranjol; Eldar A Nadyrov
Journal:  Molecules       Date:  2022-01-18       Impact factor: 4.411

5.  Association of β-Catenin, APC, SMAD3/4, Tp53, and Cyclin D1 Genes in Colorectal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Hongfeng Yan; Fuquan Jiang; Jianwu Yang
Journal:  Genet Res (Camb)       Date:  2022-08-17       Impact factor: 1.375

6.  Apparent Diffusion Coefficient (ADC) value: a potential imaging biomarker that reflects the biological features of rectal cancer.

Authors:  Yiqun Sun; Tong Tong; Sanjun Cai; Rui Bi; Chao Xin; Yajia Gu
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.